The accuracy of digital symptom checkers for both triage and diagnosis is generally low, which could pose a risk to patient safety, according to a review of studies published in npj Digital Medicine.
Researchers compiled 10 studies that evaluated a total of 48 online symptom checkers. Half of the studies used real patients, while the other half studied simulated cases. The review found primacy...
Japanese startup Ubie has scored $26.2 million in its first Series C funding round, participated by its new investors Norinchukin Capital Co., NVenture Capital Ltd., Dai-ichi Life Insurance Co., and Egg FORWARD. The round was also joined by its existing investor SUZUKEN Co.
This brings its total capital raised since inception to almost $60 million.
Founded in 2017, Ubie offers two AI-powered...
Japanese medtech startup Ubie has launched its AI symptom checker in the United States.
The web-based Ubie AI Symptom Checker generates relevant questions about a user's symptoms from around 3,500 question data types based on its database of 50,000 medical papers.
After answering about 20 questions, users can discover related diseases and more detailed information about their possible conditions...
The partnership will help visitors to Bayer websites for Aspirin, Aleve, Midol, Cenesten and Iberogast to access Ada’s intelligent symptom assessment platform.
Using an AI-based health assessment platform, Berlin-based Ada Health assists users in identifying the correct care, based on their individual requirements, risk factors and symptoms.
The free app provides guidance via an AI chatbot which...
When someone comes down with a new health symptom, they are typically advised not to self-diagnose using the internet. Resorting to Dr. Google could lead to inaccurate diagnosis, incorrect treatments or increased anxiety.
But new research published in JAMA Network Open suggests that online investigations for health information actually lead to slightly more accurate diagnoses.
TOPLINE DATA...
K Health, a startup combining a free symptom checker with text-based telehealth and virtual primary care, has announced $132 million Series E – its third major raise within the course of a year.
GGV Capital, Valor Equity Partners and Kaiser Permanente pension fund headlined the raise, with GGV Managing Partner Hans Tung and Valor founder and CEO Antonio Gracias joining K Health's board. Other...
This morning, Infermedica, a Wrocław, Poland-based artificial intelligence triage system, announced that it closed its Series A funding round with $10.25 million.
European Bank for Reconstruction and Development and Heal Capital led the round with participation from Karma Ventures, Inovo Venture Partners and Dreamit Ventures.
This comes roughly a year after Infermedica announced a $3.65 million ...
Satisfaction with COVID-19 screening chatbots and adherence to the information they provide is primarily driven by the user's perception of the tool's ability, according to research recently published in the Journal of the American Medical Informatics Association.
Conducted by researchers from Indiana University and Temple University's respective business schools, the investigation asked...
U.K. and U.S. residents who reported a loss of smell and taste into a COVID-19 symptom-tracker app more often tested positive for the infection, according to a study published yesterday in Nature.
The COVID Symptom Study app was developed by health technology company Zoe Global with help from King's College London and Massachusetts General Hospital. It launched in the U.K. and the U.S. in late...
Swedish telehealth provider LIVI has launched the first UK national guidelines for NHS GPs on how to spot and manage COVID-19 symptoms in patients via video, phone or online consultations.
The guidance, produced by LIVI’s clinical team of NHS doctors, aims is to help UK doctors identify early signs of COVID-19 and better understand how it develops.
Founded in Sweden in 2015 under the name KRY,...
